Anesthetic Drugs In Neonates Flashcards
Factors affecting metabolism of drugs (4)
- Larger volume of distribution - increase dose for water soluble medications
- Decreased protein binding - increase free drug levels leading to increase activity and toxicity
- Decreased body fat percentage - decrease amount of fat and muscle mass leading to greater levels of drugs that are primarily distributed to muscle and fat
- Immature renal and hepatic function - increase blood levels from normal dose
Helpful in decreasing secretions and response to vagal stimulation on intubation
Anticholinergics:
Atropine
Glycopyrrolate
Atropine dose in neonates
- IV
- IM
- IV 10 mcg/kg or 0.01 mg/kg
2. IM 20 mcg/kg or 0.02 mg/kg
Caution should be exercised if neonates have other associated congenital abnormalities particularly _____________ due to possible increase in IOP
Narrow angle glaucoma
An anticholinergic which is a synthetic quaternary ammonium, has longer duration than atropine, less central effects because of decreased penetration of BBB
Glycopyrrolate
No sedative effects
Clearance of midazolam is _________ in neonates and premature infants
LOWER
Hence caution has to be exercised
May cause hypotension if combined with opioids
THIOPENTAL
- Dose
- Clearance
- Duration
- Hemodynamic effects
- Contraindication
- Dose - 2 to 4 mg/kg (larger doses required due to large volume of distribution)
- Clearance - Reduced
- Duration - Longer than anticipated
- Hemodynamic effects - can cause HYPOTENSION in volume depleted neonates
- Contraindication - Neonates with CHD due to effect on myocardial function
Most commonly used IV induction agent in the United states
PROPOFOL
Phenol derivative sedative/hypnotic
Maintain adequate hemodynamics in neonate
KETAMINE, an NMDA antagonist
- Induction dose IV/IM
- Indication
- Side effects
- Induction dose
IV 2 mg/kg
IM 4-7 mg/kg - Indication - neonates with cardiovascular instability or with CHD
- Side effects - increase oral secretions
DEXMEDETOMEDINE, an alpha 2 receptor agonist
- Dose for sedation same as adult: 0.2-0.6 mcg/kg/hr
- Has not been FDA approved for use in neonatal population
- Adjunct to general anesthesia
- Effective for sedation of term and preterm undergoing mech vent
- Reduce required dise of midazolam and fentanyl
FENTANYL, a synthetic opioid
- Dose 2-4 mcg/kg/hr can maintain hemodynamic stability
- Adverse reactions:
- hypotension (if with benzodiazepine)
- respiratory depression (continuous infusion > boluses)
- chest wall and glottic rigidity (1-2 mcg/kg)
- desaturation
MORPHINE
- Decreased clearance - dosing should occur on a 4-6 hour basis
- Postoperative pain contril in ICU
- Metabolites: M3G and M6G
M6G - respiratory depression
Sensitivity to M6G increases with age due to increased maturation of neuronal receptors
REMIFENTANIL
- Ultra short acting - half life 10 mins
- Metabolized by: NONSPECIFIC ESTERASE
- Used for maintenance of anesthesia with avoidance of volatile anesthesia
METHADONE
- Long acting opioid
- Used in managing OPIOID TOLERANCE/WITHDRAWAL
- Avoid use in patients with prolonged QT interval
Only depolarizing muscle relaxant; has the most rapid onset time
SUCCINYLCHOLINE